IAP and death receptors-targeted therapies in bladder cancer.
Department of Antibody Engineering, Genentech Inc., San Francisco, CA, USA.
Zhaoyu
Z
Jin
D045744:Cell Line, Tumor; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D058990:Molecular Targeted Therapy / Q000379:methods; D053218:Receptors, Death Domain / Q000819:agonists* / Q000378:metabolism; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000494:pharmacology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D051034:Inhibitor of Apoptosis Proteins; D053218:Receptors, Death Domain; D053221:TNF-Related Apoptosis-Inducing Ligand